首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿斯匹林对2型糖尿病血清C-反应蛋白及糖尿病肾病发生的影响
引用本文:权晓娟,王小峰,王妮.阿斯匹林对2型糖尿病血清C-反应蛋白及糖尿病肾病发生的影响[J].军医进修学院学报,2012(10):1031-1032,1041.
作者姓名:权晓娟  王小峰  王妮
作者单位:1. 西安交通大学医学院第二附属医院,陕西西安 710004
2. 陕西省商洛市商州区大荆中心卫生院,陕西商洛 726001
基金项目:陕西省科技攻关项目[2006K14-G11(2)]
摘    要:目的探讨阿斯匹林对2型糖尿病(T2DM)患者血清超敏C-反应蛋白(hs-CRP)的影响与糖尿病肾病发生的关系.方法107例T2DM患者随机分为:A组48例口服阿斯匹林100mg/晚;B组59例维持原抗糖尿病治疗方案.经过12个月治疗后观察患者血清hs-CRP、尿白蛋白排泄率(UAER)、空腹血糖(FBG)、糖化血红蛋白(HbA1c)、空腹胰岛素(INS)、空腹C肽、甘油三脂(TG)、胆固醇(TC)等指标的变化.结果两组比较,FBG、HbA1c、INS、C肽、TG、TC差异无统计学意义(P>0.05);A组治疗后与治疗前比较,hs-CRP降低(P<0.05),UAER升高,但P>0.05;B组治疗后较治疗前hs-CRP、UAER升高(P<0.01).B组较A组hs-CRP、UAER升高(P<0.01).结论阿斯匹林可以降低T2DM患者血清hs-CRP,对糖尿病肾病的发生有一定的预防和预测作用.

关 键 词:2型糖尿病肾病  阿斯匹林  血清超敏C-反应蛋白

Effect of aspirin on C-reactive protein and diabetic nephropathy in type 2 diabetes mellitus patients
QUAN Xiao juan,WANG Xiao feng,WANG Ni.Effect of aspirin on C-reactive protein and diabetic nephropathy in type 2 diabetes mellitus patients[J].Academic Journal of Pla Postgraduate Medical School,2012(10):1031-1032,1041.
Authors:QUAN Xiao juan  WANG Xiao feng  WANG Ni
Institution:1Second Affiliated Hospital of Xi’an Jiaotong University Medical College,Xi’an 710004,Shaanxi Province,China;2Shangzhou Dajing Central Hospital,Shangluo 726001,Shaanxi Province,China
Abstract:Objective To study the effect of aspirin on serum high sensitive C-reactive protein(hs-CRP)in type 2 diabetes mellitus(T2DM) patients and its relation with diabetic nephropathy.Methods One hundred and seven T2DM patients were randomly divide into group A(n=48) and group B(n=59).Patients in group A took 100mg aspirin per os/night and those in group B received routine anti-diabetic therapy for 12 months,then serum levels of hs-CRP,urinary albumin excretion rate(UAER),fast blood glucose(FBG),glycosylated hemoglobin(HbA1c),fasting insulin(INS),fasting C peptide,triglyceride(TG) and total cholesterol(TC) were measured.Results No significant difference was found in serum levels of FBG,HbA1c,INS,fasting C peptide,TG and TC between the two groups(P>0.05).The serum hs-CRP level was lower while the serum UAER level was higher in group A after treatment than before treatment(P<0.05).The serum hs-CRP and UAER levels were higher in group B after treatment than before treatment(P<0.01).The serum hs-CRP and UAER levels were higher in group B than in group A(P<0.01).Conclusion Aspirin can reduce the serum hs-CRP level in T2DM patients and plays a certain role in prevention and prediction of diabetic nephropathy.
Keywords:type 2 diabetic nephropathy  aspirin  high sensitive C reactive protein
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号